316 related articles for article (PubMed ID: 16650744)
1. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Lekkas A; Gyi KM; Hodson ME
J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
[TBL] [Abstract][Full Text] [Related]
2. Temocillin in cystic fibrosis: a retrospective pilot study.
Kent L; Bradley JM; France M; Döring G; Carryn S; Bradbury I; Rendall J; Jones A; Elborn JS
J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres.
Boussaud V; Guillemain R; Grenet D; Coley N; Souilamas R; Bonnette P; Stern M
Thorax; 2008 Aug; 63(8):732-7. PubMed ID: 18408050
[TBL] [Abstract][Full Text] [Related]
4. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
[TBL] [Abstract][Full Text] [Related]
5. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
Lynch JP
Semin Respir Crit Care Med; 2009 Oct; 30(5):596-610. PubMed ID: 19760547
[TBL] [Abstract][Full Text] [Related]
6. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA
J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
[TBL] [Abstract][Full Text] [Related]
7. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
[TBL] [Abstract][Full Text] [Related]
8. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
[TBL] [Abstract][Full Text] [Related]
9. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
Kitt H; Lenney W; Gilchrist FJ
BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
[TBL] [Abstract][Full Text] [Related]
10. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.
Weidmann A; Webb AK; Dodd ME; Jones AM
J Cyst Fibros; 2008 Sep; 7(5):409-11. PubMed ID: 18356119
[TBL] [Abstract][Full Text] [Related]
12. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
Taylor RF; Gaya H; Hodson ME
J Antimicrob Chemother; 1992 Mar; 29(3):341-4. PubMed ID: 1375595
[TBL] [Abstract][Full Text] [Related]
13. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
Bernhardt SA; Spilker T; Coffey T; LiPuma JJ
Clin Infect Dis; 2003 Sep; 37(6):780-5. PubMed ID: 12955638
[TBL] [Abstract][Full Text] [Related]
14. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center.
Kennedy MP; Coakley RD; Donaldson SH; Aris RM; Hohneker K; Wedd JP; Knowles MR; Gilligan PH; Yankaskas JR
J Cyst Fibros; 2007 Jul; 6(4):267-73. PubMed ID: 17137846
[TBL] [Abstract][Full Text] [Related]
15. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis.
Downey DG; Martin SL; Dempster M; Moore JE; Keogan MT; Starcher B; Edgar J; Bilton D; Elborn JS
Pediatr Pulmonol; 2007 Mar; 42(3):216-20. PubMed ID: 17238189
[TBL] [Abstract][Full Text] [Related]
16. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR
J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
[TBL] [Abstract][Full Text] [Related]
18. Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?
Olland A; Falcoz PE; Kessler R; Massard G
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):631-4. PubMed ID: 21920934
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
Van Acker H; Van Snick E; Nelis HJ; Coenye T
J Cyst Fibros; 2010 Dec; 9(6):450-4. PubMed ID: 20851061
[TBL] [Abstract][Full Text] [Related]
20. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
Herasimenka Y; Cescutti P; Impallomeni G; Campana S; Taccetti G; Ravenni N; Zanetti F; Rizzo R
J Cyst Fibros; 2007 Apr; 6(2):145-52. PubMed ID: 16860003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
